Shaanxi Micot Pharmaceutical Technology Co., Ltd.

Research Shaanxi Micot Pharmaceutical Technology Co., Ltd. (2335.HK) with Bullrun company financials, valuation charts, model signals, and historical stock context.

Key Metrics

Ticker2335.HK
ExchangeHK
CountryChina
SectorHealthcare
IndustryBiotechnology
CurrencyHKD
Financial periodFY2025
RevenueCNY 0
Net income-CNY 182.51M
Free cash flow-CNY 154.08M

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	CNY 0	-CNY 182.51M	-CNY 154.08M	n/a	n/a	CNY 80.56M	CNY 49.70M	-CNY 972.46M
FY2024	CNY 0	-CNY 154.63M	-CNY 109.04M	n/a	-0.47	CNY 64.66M	CNY 46.55M	CNY 111.81M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-11-11	n/a	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 HKD.

About Shaanxi Micot Pharmaceutical Technology Co., Ltd.

Shaanxi Micot Pharmaceutical Technology Co., Ltd. engages in discovery, development and commercialization of bi-/multi-specific peptide drugs. The company engages in discovery, development and commercialization of bi-/multi-specific peptide drugs for the treatment of metabolic diseases as well as for cancer, cardiovascular, cerebrovascular, and neurological systemic diseases. The company was founded in founded in 2007 and is headquartered in Xi'an, China.

Related stock research

China stocks China Healthcare stocks A-Z stock index

Other Healthcare stocks

Hualan Biological Engineering INC (002007.SZ) Shanghai RAAS Blood Products Co Ltd (002252.SZ) Asymchem Laboratories (Tianjin) Co., Ltd. (002821.SZ) Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) CANbridge Pharmaceuticals Inc. (1228.HK) 3D Medicines Inc. (1244.HK) Ocumension Therapeutics (1477.HK) 3SBio Inc. (1530.HK) LongBio Pharma (Suzhou) Co., Ltd. (1779.HK) Innovent Biologics, Inc. (1801.HK) Viva Biotech Holdings (1873.HK) BioDlink International Company Limited (1875.HK)